These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28885019)

  • 21. Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders.
    Roncarati R; Scali C; Comery TA; Grauer SM; Aschmi S; Bothmann H; Jow B; Kowal D; Gianfriddo M; Kelley C; Zanelli U; Ghiron C; Haydar S; Dunlop J; Terstappen GC
    J Pharmacol Exp Ther; 2009 May; 329(2):459-68. PubMed ID: 19223665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of novel 2-((pyridin-3-yloxy)methyl)piperazines as α7 nicotinic acetylcholine receptor modulators for the treatment of inflammatory disorders.
    Clark RB; Lamppu D; Libertine L; McDonough A; Kumar A; LaRosa G; Rush R; Elbaum D
    J Med Chem; 2014 May; 57(10):3966-83. PubMed ID: 24814197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tropisetron sensitizes α7 containing nicotinic receptors to low levels of acetylcholine in vitro and improves memory-related task performance in young and aged animals.
    Callahan PM; Bertrand D; Bertrand S; Plagenhoef MR; Terry AV
    Neuropharmacology; 2017 May; 117():422-433. PubMed ID: 28259598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and Biological Evaluation of Novel Triazine Derivatives as Positive Allosteric Modulators of α7 Nicotinic Acetylcholine Receptors.
    Wang X; Xiao H; Wang J; Huang Z; Peng G; Xie W; Bian X; Liu H; Shi C; Yang T; Li X; Gao J; Meng Y; Jiang Q; Chen W; Hu F; Wei N; Wang X; Zhang L; Wang K; Sun Q
    J Med Chem; 2021 Aug; 64(16):12379-12396. PubMed ID: 34374537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring the binding energy profiles of full agonists, partial agonists, and antagonists of the α7 nicotinic acetylcholine receptor.
    Tabassum N; Ma Q; Wu G; Jiang T; Yu R
    J Mol Model; 2017 Sep; 23(9):251. PubMed ID: 28770361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and Synthesis of a New Series of 4-Heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes as α7 Nicotinic Receptor Agonists. 1. Development of Pharmacophore and Early Structure-Activity Relationship.
    Cook J; Zusi FC; McDonald IM; King D; Hill MD; Iwuagwu C; Mate RA; Fang H; Zhao R; Wang B; Cutrone J; Ma B; Gao Q; Knox RJ; Matchett M; Gallagher L; Ferrante M; Post-Munson D; Molski T; Easton A; Miller R; Jones K; Digavalli S; Healy F; Lentz K; Benitex Y; Clarke W; Natale J; Siuciak JA; Lodge N; Zaczek R; Denton R; Morgan D; Bristow LJ; Macor JE; Olson RE
    J Med Chem; 2016 Dec; 59(24):11171-11181. PubMed ID: 27958732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test.
    Andreasen JT; Nielsen EØ; Christensen JK; Olsen GM; Peters D; Mirza NR; Redrobe JP
    J Psychopharmacol; 2011 Oct; 25(10):1347-56. PubMed ID: 20360159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective activation of α7 nicotinic acetylcholine receptors augments hippocampal oscillations.
    Stoiljkovic M; Kelley C; Nagy D; Leventhal L; Hajós M
    Neuropharmacology; 2016 Nov; 110(Pt A):102-108. PubMed ID: 27422408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unique pharmacology of heteromeric α7β2 nicotinic acetylcholine receptors expressed in Xenopus laevis oocytes.
    Zwart R; Strotton M; Ching J; Astles PC; Sher E
    Eur J Pharmacol; 2014 Mar; 726():77-86. PubMed ID: 24485886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of BMS-902483, an α7 nicotinic acetylcholine receptor partial agonist, on cognition and sensory gating in relation to receptor occupancy in rodents.
    Pieschl RL; Miller R; Jones KM; Post-Munson DJ; Chen P; Newberry K; Benitex Y; Molski T; Morgan D; McDonald IM; Macor JE; Olson RE; Asaka Y; Digavalli S; Easton A; Herrington J; Westphal RS; Lodge NJ; Zaczek R; Bristow LJ; Li YW
    Eur J Pharmacol; 2017 Jul; 807():1-11. PubMed ID: 28438647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo neuronal nicotinic receptor properties of (+)- and (-)-pyrido[3,4]homotropane [(+)- and (-)-PHT]: (+)-PHT is a potent and selective full agonist at α6β2 containing neuronal nicotinic acetylcholine receptors.
    Carroll FI; Navarro HA; Mascarella SW; Castro AH; Luetje CW; Wageman CR; Marks MJ; Jackson A; Damaj MI
    ACS Chem Neurosci; 2015 Jun; 6(6):920-6. PubMed ID: 25891987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. α7-nAChR agonist enhances neural plasticity in the hippocampus via a GABAergic circuit.
    Townsend M; Whyment A; Walczak JS; Jeggo R; van den Top M; Flood DG; Leventhal L; Patzke H; Koenig G
    J Neurophysiol; 2016 Dec; 116(6):2663-2675. PubMed ID: 27655963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relation between structure and muscarinic activity III. Synthesis and cholinergic activity of some-onium compounds related to 2-methyl-4-trimethylammoniomethyl-1,3-dioxolane iodide.
    Elferink JG; Salemink CA
    Arzneimittelforschung; 1975; 25(12):1858-60. PubMed ID: 1243653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of H-bonding probes of alpha7 nAChR agonist selectivity.
    Wang J; Papke RL; Horenstein NA
    Bioorg Med Chem Lett; 2009 Jan; 19(2):474-6. PubMed ID: 19081250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel 5-(quinuclidin-3-ylmethyl)-1,2,4-oxadiazoles to investigate the activation of the α7 nicotinic acetylcholine receptor subtype: Synthesis and electrophysiological evaluation.
    Quadri M; Silnović A; Matera C; Horenstein NA; Stokes C; De Amici M; Papke RL; Dallanoce C
    Eur J Med Chem; 2018 Dec; 160():207-228. PubMed ID: 30342362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. JN403, in vitro characterization of a novel nicotinic acetylcholine receptor alpha7 selective agonist.
    Feuerbach D; Nozulak J; Lingenhoehl K; McAllister K; Hoyer D
    Neurosci Lett; 2007 Apr; 416(1):61-5. PubMed ID: 17314009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Unaltered Orthosteric Site and a Network of Long-Range Allosteric Interactions for PNU-120596 in α7 Nicotinic Acetylcholine Receptors.
    Marotta CB; Lester HA; Dougherty DA
    Chem Biol; 2015 Aug; 22(8):1063-73. PubMed ID: 26211363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding Interactions of NS6740, a Silent Agonist of the
    Blunt CEW; Dougherty DA
    Mol Pharmacol; 2019 Aug; 96(2):212-218. PubMed ID: 31175182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-activity relationship studies of SEN12333 analogues: determination of the optimal requirements for binding affinities at α7 nAChRs through incorporation of known structural motifs.
    Beinat C; Reekie T; Banister SD; O'Brien-Brown J; Xie T; Olson TT; Xiao Y; Harvey A; O'Connor S; Coles C; Grishin A; Kolesik P; Tsanaktsidis J; Kassiou M
    Eur J Med Chem; 2015 May; 95():277-301. PubMed ID: 25827398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substituted 2-Aminopyrimidines Selective for α7-Nicotinic Acetylcholine Receptor Activation and Association with Acetylcholine Binding Proteins.
    Kaczanowska K; Camacho Hernandez GA; Bendiks L; Kohs L; Cornejo-Bravo JM; Harel M; Finn MG; Taylor P
    J Am Chem Soc; 2017 Mar; 139(10):3676-3684. PubMed ID: 28221788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.